Genprex
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Genprex and other ETFs, options, and stocks.About GNPX
Genprex, Inc. is a clinical-stage gene therapy company, which engages in the development of therapies for patients with cancer and diabetes. The company product is REQORSA immunogen therapy drug for non-small cell lung cancer.
GNPX Key Statistics
Stock Snapshot
Genprex(GNPX) stock is priced at $2.88, giving the company a market capitalization of 6.91M. It carries a P/E multiple of -0.06.
On 2025-11-29, Genprex(GNPX) stock traded between a low of $2.88 and a high of $3.07. Shares are currently priced at $2.88, which is 0.0% above the low and -6.2% below the high.
Genprex(GNPX) shares are trading with a volume of 74.43K, against a daily average of 262.41K.
During the past year, Genprex(GNPX) stock moved between $2.77 at its lowest and $63.00 at its peak.
During the past year, Genprex(GNPX) stock moved between $2.77 at its lowest and $63.00 at its peak.
GNPX News
Genprex (GNPX) announced the publication of data from its Acclaim-1 Phase 1 clinical trial of Reqorsa Gene Therapy in combination with Tagrisso in patients with...